Business Wire

NY-UPTIME-INSTITUTE

20.9.2022 12:03:37 CEST | Business Wire | Press release

Share
Uptime Institute’s 2022 Global Data Center Survey Reveals Strong Industry Growth as Operators Brace for Expanding Sustainability Requirements

Uptime Institute today announced the release of its 12th Annual Global Data Center Survey. The findings show an industry that is growing, dynamic and increasingly resilient, but still working to address increasing pressure for sustainability progress and reporting, continuing staffing shortages, supply chain delays, costly outages and other complex challenges.

“The global digital infrastructure sector continues to enjoy strong growth and expansion, despite the many obstacles operators are facing today,” said Andy Lawrence, executive director of research, Uptime Institute Intelligence. “We’ve seen the industry invest in increased resiliency and reliability, but there’s still work to be done when it comes to improving efficiency, environmental sustainability, outage prevention, staffing pipelines and more.”

Uptime’s annual Global Data Center Survey is the largest and most comprehensive in the digital infrastructure industry. It provides detailed insights into the digital critical infrastructure landscape and a sense of its future trajectory. Key findings from the 2022 report include:

  • Many data center operators are unprepared for mounting sustainability requirements and regulations – Most respondents say they report on overall data center power use and PUE, but many still are not tracking critical environmental metrics. Although 63% of operators believe authorities in their region will require them to publicly report environmental data in the next five years, just 37% collect and report carbon emissions data (a slight increase over 33% in 2021) and only 39% currently report their water use (a 12% drop compared to 2021). New laws, standards, and requirements will force operators to address these gaps and establish more stringent sustainability tracking and reporting practices in the coming years.
  • PUE progress is in stasis for now and future efficiency gains must focus on IT power – The average annual power usage effectiveness (PUE) reported in 2022 was 1.55. This represents a slight improvement over the 2021 average of 1.57, which is consistent with the trend of marginal PUE gains Uptime has observed annually since 2014. Going forward, achieving substantial data center efficiency improvements will require a new focus on IT efficiency, along with metrics to track and report progress.
  • More operators are investing to bolster data center resiliency – Data center owners and operators are making significant investments in the resiliency of their physical infrastructure, with about 40% of respondents reporting increased redundancy levels at their primary data centers in the past three to five years. Power and cooling systems have received similar attention, with a third of operators upgrading either or both.
  • Outages are becoming more expensive and are still far too frequent – The share of all outages costing operators over $1 million has reached 25%, a significant increase from 15% in 2021. In 2022, 60% of operators reported experiencing an outage (regardless of severity) in the past three years — down from 69% in 2021 and 78% in 2020. Although the data indicates a trend toward improved outage rates, the frequency of outages is still much too high and with more than two-thirds now costing operators upwards of $100,000, the consequences are getting worse.
  • Operators’ confidence in public cloud is on the rise, despite ongoing outage risks – As the perception of improved visibility into cloud operational resiliency grows, organizations are more likely to trust the cloud for mission-critical workloads. In 2022, just 63% of operators are not placing mission-critical workloads into a public cloud, a substantial drop from almost 75% in 2019. That trust might be misplaced, given that more than one-third of respondents report that public cloud availability zone outages (which are relativity common) would cause significant performance issues.
  • Data center equipment vendors optimistic despite demand pressures and lingering supply chain problems – Three-quarters of vendors project year-over-year revenue growth in 2022 despite reporting dampened revenues due to persistent COVID-induced supply chain issues. Nearly half of respondents involved with data center construction have suffered significant delays (or other events) in their supply chains, while one-third have experienced moderate issues.
  • Problems attracting and retaining qualified staff are worsening – Over half (53%) of data center operators report difficulty finding qualified employees in 2022 — up from 47% in 2021 and 38% in 2018. And 42% of respondents report issues with staff being hired away (in most cases to data center competitors) – a massive increase over just 17% in 2018, which demonstrates the growing challenge of employee retention throughout the sector.

Learn More: Uptime’s 2022 Global Data Center Survey also includes findings on industry attitudes toward nuclear energy, server refresh rates, rack density trends and much more. Download the complete report here, and register for the webinar covering its key trends and takeaways on September 28th at 11:00 a.m. ET.

About the Survey: Uptime conducts its annual Global Data Center Survey online and by email. This year’s study took place in H1 2022, and includes responses from approximately 800 data center owners and operators responsible for managing infrastructure at the world’s largest IT organizations. It also includes insights from 700 data center suppliers, designers, and advisors worldwide.

About Uptime Institute

Uptime Institute is the Global Digital Infrastructure Authority. For over 25 years, the company has established industry-leading benchmarks for data center performance, resilience, sustainability, and efficiency, which provide customers assurance that their digital infrastructure can perform across a wide array of operating conditions at a level consistent with their business needs. Uptime’s Tier Standard is the IT industry’s most trusted and adopted global standard for the design, construction, and operation of data centers – the backbone of the digital economy. With its Tier Standard and Certifications, Management & Operations reviews, SCIRA-FSI financial sector risk assessment, broad range of additional risk and performance assessments, Intelligence research services, and accredited training courses completed by over 10,000 data center professionals, Uptime has helped thousands of companies in over 100 countries to optimize critical IT assets while managing costs, resources, and efficiency.

Uptime Institute is headquartered in New York, NY, with offices in Seattle, London, Sao Paulo, Dubai, Singapore, and Taipei. For more information, please visit www.uptimeinstitute.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220920005231/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release

Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b

LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release

The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen

Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye